AC Immune is a clinical-stage biopharmaceutical company that is pioneering precision medicine for neurodegenerative diseases. AC Immune focuses on neurodegenerative diseases with product candidates in clinical trials.
AC Immune is passionate about making the difference in the lives of people who are affected by Alzheimer’s and other neurodegenerative diseases. Its goal is to become a global leader in precision medicine of neurodegenerative disease, which is one of the biggest challenges facing the society today and the future generations.
The company has a broad pipeline that focuses on neurodegenerative diseases with complementary diagnostic agents that are driven by proprietary technology platforms.
The therapeutic and diagnostic agents of AC Immune are at the forefront of fighting against one of world’s greatest healthcare challenges, the need to develop reliable and accurate diagnostics and disease modifying treatments to improve the lives of patients who are suffering from Alzheimer’s and other neurodegenerative diseases.